Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2003 December;47(4)

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

 

The Quarterly Journal of Nuclear Medicine 2003 December;47(4)

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):223-37

Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases

Sosabowsky J., Melendez-Alafort L., Mather S.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):238-45

99mTc-Antimicrobial peptides: promising candidates for infection imaging

Lupetti A., Pauwels E. K. J., Nibbering P. H., Welling M. M.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):246-55

Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation

Van Eerd J. E. M., Boerman O. C., Corstens F. H. M., Oyen W. J. G.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):256-69

The developing role of peptide radiopharmaceuticals in the study of chronic inflammation: new techniques for novel therapeutic options

Chianelli M., Parisella M. G., D’Alessandra C., Corsetti F., Scopinaro F., Signore A.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):270-8

The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis

Dalm V. A. S. H., Van Hagen P. M., Krenning E. P.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):279-91

Non-oncologic applications of radiolabeled peptides in nuclear medicine

Knight L. C.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):292-320

“Pathophysiologic mapping” of venous thromboembolism: opportunities for radiolabeled peptides

Bernarducci M. P.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):321-36

Radiolabelled peptides and low molecular weight proteins in metabolic diseases

Aprile C.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):337-48

Imaging cell death in vivo

Blankenberg F., Mari C., Strauss H. W.

Abstract PDF

  USE OF RADIOLABELLED PEPTIDES FOR SCINTIGRAPHY IN NON-ONCOLOGIC DISEASES

The Quarterly Journal of Nuclear Medicine 2003 December;47(4):349-61

The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging

Kietselaer B. L. J. H., Hofstra L., Dumont E. A. W., Reutelingsperger C. P. M., Heidendal G. A. K.

Abstract PDF

inizio pagina